A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

Summary

This study is a multisite, randomized, double-blind, placebo-controlled, phase 2/3 study of MG01CI (1400 mg daily) for 6 weeks compared with placebo in a 1:1 ratio of 300 adults with ADHD.

Timeline

Start

2014-03

Primary completion

2014-09

Completion

2014-09

Outcome

Missed primary endpoint

registry p = 0.1358; Least Square Mean Difference -2.10 (95% CI -4.87 to 0.66) NCT02059642 ↗

Drugs

Indications